Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|November 18, 2003
Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?Kety Hsieh, Paul Knöbl, Claudia Rintelen, et al.
Thrombosis and Haemostasis|January 18, 2006
The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemiaAlexander O Spiel, Christa Firbas, Florian B Mayr, et al.
Journal of Thrombosis and Haemostasis : JTH|July 11, 2024
Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mLBert Verbruggen, Nikolaus B Binder, Petra J C van Velp, et al.
Critical Care Medicine|April 10, 2002
Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditionsCatharina Wenzel, Brigitte Stoiser, Gottfried J Locker, et al.
Journal of Thrombosis and Haemostasis : JTH|August 27, 2019
Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 StudyHalet Türkantoz, Christoph Königs, Paul Knöbl, et al.
Deutsche Medizinische Wochenschrift (1946)|November 6, 2024
[100 years thrombotic thrombocytopenic purpura (TTP) - lessons learned?]Ralph Wendt, Linus Völker, Martin Bommer, et al.
Frontiers in Medicine|July 28, 2022
Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life SupportMarion Wiegele, Daniel Laxar, Eva Schaden, et al.
Journal of Thrombosis and Haemostasis : JTH|April 20, 2021
Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)Johannes Thaler, Cihan Ay, Karoline V Gleixner, et al.
Critical Care Medicine|July 14, 2021
Prevalence and Clinical Impact of Reduced Coagulation Factor XII Activity in Patients Receiving Extracorporeal Membrane OxygenationNina Buchtele, Michael Schwameis, Peter Schellongowski, et al.
Vox Sanguinis|April 26, 2006
Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin)Peter Schellongowski, Edith Bauer, Ulrike Holzinger, et al.
Pageof 8